LLY Eli Lilly and Company

32.39

-0.61 (-1.85%)

Last Updated: 19:16:07

Delayed by 15 minutes

Name	Symbol	Market	Type
Eli Lilly and Company	NEO:LLY	NEO	Depository Receipt

	Price Change	% Change	Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Traded	Last Trade
	-0.61	-1.85%	32.39	32.39	32.45	32.86	32.13	32.81	23,232	19:16:07

Multiple Clinical Trial Analysis Shows Duloxetine Reduces Stress Urinary Incontinence Episodes and Improves Quality of Life for

29/06/2004 8:00am

PR Newswire (US)

Eli Lilly (NEO:LLY)
Historical Stock Chart

From Jul 2019 to Jul 2024

Multiple Clinical Trial Analysis Shows Duloxetine Reduces Stress Urinary Incontinence Episodes and Improves Quality of Life for Women MONTE CARLO, Monaco, June 29 /PRNewswire-FirstCall/ -- Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI). Stress urinary incontinence is an embarrassing and bothersome medical condition, which affects nearly 15 million adult women in the United States(1,2,3) and can have a significant impact on quality of life. Results from a worldwide, four-study meta- analysis, comparing the efficacy of duloxetine and placebo in more than 1,900 women, demonstrated a statistically significant improvement after 12 weeks, compared to placebo (p